The Proteus Discover, an ingestible sensor technology developed by Proteus to monitor treatment efficacy in patients, is currently being trialled in Children’s Health in Dallas, Texas on at least one children recovering from organ transplants. The medication management and adherence system uses a tablet app to display its readings taken via sensor-enabled pills and a wearable peel-and-stick biometric sensor patch. The hospital plans to release a whitepaper on the trial once finished.
The Proteus Discover, an ingestible sensor technology developed by Proteus to monitor treatment efficacy in patients, is currently being trialled in Children’s Health in Dallas, Texas on 15 children recovering from organ transplants. The medication management and adherence system uses a tablet app to display its readings taken via sensor-enabled pills and a wearable peel-and-stick biometric sensor patch. The hospital plans to release a whitepaper on the trial once finished.